SCHEMBL6569244

SCHEMBL6569244

Cc1cc(Cl)ccc1OC1CCN(C2CCN(C(=O)c3ccccc3Cl)CC2)CC1

nearest known ligand 0.59

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 8/20 0.59
CCR3 P51677 8/20 0.59
CHRM1 P11229 1/20 0.54
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
GAA P10253 1/20 0.50
CHRM2 P08172 3/20 0.49
MGLL Q99685 2/20 0.48
RAB9A P51151 1/20 0.47
PDE4B Q07343 1/20 0.47
TP53BP1 Q12888 1/20 0.46
L3MBTL3 Q96JM7 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KCNH2 Q12809 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6569293 0.86 CCR3 (0.65) HRH1CCR3KDM4EALDH1A1GAA
SCHEMBL6567690 0.85 CCR3 (0.63) HRH1CCR3CHRM1MGLLTP53BP1
SCHEMBL5415084 0.82 HRH1 (0.62) HRH1CCR3CHRM1KCNH2
SCHEMBL6568902 0.82 HRH1 (0.59) HRH1CCR3KDM4EALDH1A1MGLL
SCHEMBL6569270 0.81 HRH1 (0.58) HRH1CCR3KDM4EALDH1A1GAA
SCHEMBL5414562 0.81 HRH1 (0.75) HRH1CCR3KCNH2
SCHEMBL6570409 0.80 CCR3 (0.57) HRH1CCR3CHRM1TP53BP1L3MBTL3
SCHEMBL6567607 0.80 CCR3 (0.57) HRH1CCR3TP53BP1L3MBTL3L3MBTL1
SCHEMBL5405625 0.79 HRH1 (0.78) HRH1CCR3CHRM1L3MBTL3L3MBTL1
SCHEMBL5411547 0.78 HRH1 (0.86) HRH1CCR3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404667-A1 PIPERIDINE DERIVATIVES USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY AstraZeneca AB (SE) 2004-04-07 EP disclosed
WO-2003004487-A1 PIPERIDINE DERIVATIVES USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY ASTRAZENECA AB (SE) 2003-01-16 WO disclosed